Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Merck Sharp & Dohme LLC
Akihito Kawazoe; Rui-Hua Xu; Pilar García-Alfonso; Maria Passhak; Hao-Wei Teng; Ardaman Shergill; Mahmut Gumus; Camilla Qvortrup; Sebastian Stintzing; Kathryn Towns; Tae Won Kim; Kai Keen Shiu; Juan Cundom; Sumitra Ananda; Andrey Lebedinets; Rong Fu; Rishi Jain; David Adelberg; Volker Heinemann; Takayuki Yoshino; Elena Elez; LEAP-017 Investigators